Related by context. All words. (Click for frequent words.) 75 postintervention 72 posttransplant 72 P = .# 71 p = .# [002] 71 Postoperative 70 postprocedure 70 univariate analysis 70 postop 70 timepoints 70 PSA nadir 70 undetectable HBV DNA 70 univariate analyzes 70 HbA 1c levels 70 serum cortisol 69 biochemical relapse 69 CR nPR 69 multivariate analyzes 69 interobserver 69 % CI #.#-#.# [003] 69 μmol L 69 p = NS 69 plasma cortisol 69 F FDG PET 69 preintervention 69 PASI scores 69 MMSE score 68 hematologic parameters 68 p = #.# [003] 68 HBeAg seroconversion 68 multivariable analysis 68 CI -#.# 68 interquartile range 68 aspartate aminotransferase AST 68 nondiabetic patients 68 serum PSA 68 intact parathyroid hormone 68 virological response 68 salivary cortisol 68 TURBT 68 multivariable analyzes 68 intraobserver 68 glycated hemoglobin levels 68 colorectal adenoma 68 biochemical recurrence 68 serum testosterone 67 PaO 2 67 interobserver reliability 67 interrater reliability 67 -#.# ± [002] 67 covariate 67 spirometric 67 genotypic resistance 67 preoperative PSA 67 HBeAg negative patients 67 postinjury 67 CORE OM 67 Kaplan Meier curves 67 logistic regression analyzes 67 % Confidence Interval 67 pCR 66 periprocedural 66 EDSS scores 66 alanine aminotransferase ALT 66 glomerular filtration 66 SCr 66 postoperatively 66 serum concentrations 66 % CI #.#-#.# [008] 66 femoral shaft fracture 66 histopathological 66 serum urate levels 66 β blockers 66 methacholine challenge 66 MADRS score 66 detrusor 66 follicular phase 66 HSCT 66 HOMA IR 66 nonoperative treatment 66 haematologic 66 leukocyte count 66 NIHSS 66 posttest 66 serum estradiol 66 postoperative complication 66 perioperatively 66 mg/m2 dose 66 perioperative complications 66 Index CDAI 66 neurocognitive function 66 carotid IMT 66 virologic response 66 timepoint 66 lymphocyte count 66 multiple logistic regression 66 Subgroup analysis 66 histological subtype 66 confidence intervals CIs 66 SUVmax 66 liver histology 66 clinicopathological 66 hip BMD 66 AST ALT 66 retropubic 66 univariate 66 % CI #.#-#.# [006] 66 creatinine ratio 66 NIHSS score 66 hip resurfacing arthroplasty 66 pT3 66 specific antigen PSA 66 serum lipid levels 66 Subgroup analyzes 66 femoral neck fracture 66 logistic regression model 65 detectable HCV RNA 65 androgen suppression 65 relapsed MM 65 Crohn Disease Activity 65 RYGB 65 albumin excretion rate 65 Kaplan Meier 65 subscale scores 65 adenotonsillectomy 65 morphometric vertebral fractures 65 mg kg dose 65 Apgar scores 65 tertiles 65 postoperative chemotherapy 65 p ≤ 65 liver biopsies 65 pentoxifylline 65 oxycodone CR 65 Operative mortality 65 serum creatinine levels 65 #q# deletion syndrome 65 clinicopathological features 65 HBeAg 65 thyroglobulin 65 external beam radiotherapy 65 Kaplan Meier survival 65 clomipramine 65 WOMAC pain 65 underwent resection 65 lymphopenia 65 nodal metastases 65 CCyR 65 urodynamic 65 hemoglobin Hb 65 NMIBC 65 uM 65 multivariable logistic regression 65 lumbar spine BMD 65 primary aldosteronism 65 depressive symptomatology 65 prostate cancer CaP 65 SGPT 65 sociodemographic factors 65 HER2 expression 65 platelet reactivity 65 glycosylated hemoglobin HbA1c 65 cTnI 65 elevated creatinine 65 antibody titer 65 Histologic 65 intima media thickness 65 HER2 amplification 65 PANSS scores 65 postoperative morbidity 65 serum homocysteine 65 mL/min/#.# m 2 65 syndromal 64 Univariate 64 urine albumin 64 ALT elevation 64 solifenacin 64 rFSH 64 QTcF 64 serum IGF 64 certolizumab 64 Secondary endpoints included 64 isoprostane 64 histologic 64 detrusor overactivity 64 postoperative mortality 64 HDRS 64 SGRQ 64 postoperative complications 64 prospectively stratified 64 aspartate aminotransferase 64 immunostaining 64 Univariate analysis 64 hematological parameters 64 definite stent thrombosis 64 postoperative 64 radiographic progression 64 cytologic 64 eosinophil count 64 HRQOL 64 Serum creatinine 64 renal cysts 64 cecal intubation 64 postdischarge 64 Kaplan Meier analysis 64 DAS# remission 64 methotrexate monotherapy 64 hemodynamic variables 64 % CI #.#-#.# [007] 64 oncologic outcomes 64 DAS# CRP 64 serum uric acid 64 perioperative morbidity 64 HRCT 64 amoxicillin clavulanate 64 pmol L 64 caspofungin 64 lymphadenectomy 64 radical prostatectomy RP 64 multivariate adjustment 64 median survivals 64 inotropic 64 neutrophil counts 64 serum CRP 64 lesional 64 plasma leptin 64 Lumbar spine 64 attain statistical significance 64 conditional logistic regression 64 affective psychosis 64 P ≤ 64 p = #.# [002] 64 PSQI 64 gross hematuria 64 preoperative 64 elevated ALT 64 urinary N telopeptide 64 Secondary endpoints 64 YMRS 64 sUA 64 pretransplant 64 perioperative mortality 64 ug kg 64 NYHA functional class 64 ADAS cog 64 hypophosphatemia 64 aminotransferases 64 HoLEP 64 Postoperatively 64 nonoperative 64 covariance ANCOVA 64 Visual Analogue Scale VAS 64 logistic regression 64 GH deficiency 64 nadroparin 64 hours postdose 64 transabdominal 64 EQ 5D 64 sd = 64 symptomatic VTE 64 ejection fractions 64 μg liter 64 urine cytology 64 Flu Cy 64 creatinine levels 64 euthyroid 64 antiangiogenic therapy 64 tumor histology 64 metabolite concentrations 64 postoperative hemorrhage 64 PSADT 64 plasma creatinine 63 estimated glomerular filtration 63 percutaneous vertebroplasty 63 baseline LDH 63 Preoperatively 63 International Prostate Symptom 63 CIN3 63 GnRH agonist 63 MDRD 63 CR CRu 63 hemoglobin A1c levels 63 ANOVA 63 NNT = 63 lactate dehydrogenase 63 protein excretion 63 macroalbuminuria 63 Pharmacokinetic parameters 63 transrectal ultrasound guided 63 interobserver agreement 63 meta analytic 63 ALA PDT 63 Plasma concentrations 63 Doxil ® 63 Kruskal Wallis test 63 HbA 1c 63 lamivudine refractory patients 63 poststroke 63 CPAP adherence 63 acromegalic patients 63 bivariate 63 receiving VICTRELIS 63 Poisson regression 63 viral kinetics 63 vasopressor 63 Multivariate analysis 63 ALT flares 63 sociodemographic characteristics 63 clinically meaningful improvement 63 fasting plasma 63 serum HBV DNA 63 μg dL 63 bronchoalveolar lavage 63 coronary stenosis 63 calculated creatinine clearance 63 preoperatively 63 locomotor activity 63 chemoradiation therapy 63 pleurodesis 63 creatine kinase 63 Main Outcome Measures 63 tolterodine ER 63 hematologic toxicity 63 ertapenem 63 cystoscopic 63 thyroid carcinoma 63 â ‰ ¥ 63 oral anticoagulant therapy 63 Montgomery Åsberg Depression 63 tissue oxygenation 63 Baseline characteristics 63 sonographically guided 63 seropositivity 63 ECOG PS 63 Y BOCS 63 histologic findings 63 MMSE scores 63 Histological 63 HRQL 63 umol L 63 binary restenosis 63 troponin T 63 ‰ ¥ 63 CIN2 + 63 baseline HbA1c 63 ultrasonographic 63 estimated GFR 63 multivariate logistic regression 63 statistically significant p = 63 Secondary endpoints include 63 Main Outcome Measure 63 alanine aminotransferase 63 lymphocytosis 63 Primary endpoints 63 Psoriasis Area 63 nonpregnant women 63 lactate dehydrogenase LDH 63 IFN α 63 Insulin sensitivity 63 nonobese 63 nmol 63 Secondary efficacy endpoints 63 chest radiographs 63 Preoperative 63 bladder carcinoma 63 HbA1C levels 63 myocardial viability 63 neutropaenia 63 desvenlafaxine succinate 63 esophageal carcinoma 63 OAB symptoms 63 Bonferroni correction 63 tapentadol ER 63 endometrial carcinoma 63 dysuria 63 neurodevelopmental outcome 63 F FDG 63 TKAs 63 serum urate 63 neutrophil count 63 serum magnesium 63 Hb A1C 63 preop 63 pT2 63 leukocytosis 63 hypofractionated radiation 63 paraprotein 63 electrophysiologic 63 nonobese patients 63 arterial oxygen saturation 63 adrenalectomy 63 CDAI 63 induced sputum 63 CsA 63 sustained virological response 63 NHANES III 63 F FDG uptake 63 scintigraphic 63 atazanavir ritonavir 63 SVR# 63 plasma glucose 63 chi squared 63 T2 lesion volume 63 = #.#-#.# 63 evaluable subjects 63 μg kg 63 point Likert scale 63 Fasting plasma glucose 63 depressive symptom 63 radiotherapy RT 62 multivariate Cox 62 confidence interval CI 62 nmol l 62 endometrial thickness 62 Pain Intensity 62 serum cotinine 62 logistic regression models 62 subtrochanteric 62 anagrelide 62 radical retropubic prostatectomy 62 FOLPI 62 SLNB 62 WOMAC scores 62 dose titration 62 recurrent venous thromboembolism 62 mucosal healing 62 transient elastography 62 divalproex sodium 62 transaminase elevations 62 oral anticoagulation 62 dexmedetomidine 62 postsurgery 62 lopinavir r arm 62 IOP lowering 62 nonadherent 62 parenchymal 62 serum phosphate 62 carotid stenosis 62 glomerular filtration rate 62 eculizumab therapy 62 elevated transaminases 62 semiquantitative 62 EDSS score 62 Pearson correlation coefficient 62 salivary flow 62 Complication rates 62 adenoma detection 62 urothelial carcinoma 62 mRS 62 sonographic examinations 62 progression TTP 62 bivariate analysis 62 erythrocyte sedimentation rate 62 Postoperative complications 62 Platelet counts 62 #OHD 62 transvaginal sonography 62 androgen deprivation 62 regression coefficient 62 n = 62 ovulatory 62 ≥ 62 histologic subtype 62 histopathologic examination 62 hepatectomy 62 atherosclerotic renal artery stenosis 62 tipranavir r 62 hepatorenal syndrome 62 ischemic lesions 62 nonsignificant 62 vaginal hysterectomy 62 interferon ribavirin 62 CIMZIA ™ 62 metaplasia 62 postsurgical 62 pharmacodynamic parameters 62 left ventricular systolic 62 serum PTH 62 NIH CPSI 62 NATRECOR ® 62 alteplase 62 bortezomib refractory 62 complete cytogenetic response 62 overnight polysomnography 62 electrical cardioversion 62 premenopause 62 NNRTI resistance 62 hepatic enzyme 62 ipsilateral stroke 62 bone scintigraphy 62 primary patency 62 perfusion abnormalities 62 GOUT 62 psychiatric comorbidities 62 hyperacute 62 bivariate analyzes 62 TURP 62 serum TSH 62 hyperinsulinemic euglycemic clamp 62 metabolic parameters 62 overt nephropathy 62 hsCRP levels 62 LV ejection fraction 62 prostate carcinoma 62 Kaplan Meier estimates 62 mcg BID 62 virologic failure 62 serum phosphate levels 62 CI #.#-#.# [001] 62 parous women 62 psychiatric comorbidity 62 adjunctive placebo 62 microalbumin 62 HIV RNA 62 #mg/day [001] 62 hepatic enzymes 62 varicocele 62 Erectile function 62 creatine kinase MB 62 statistically significant p 62 adenoidectomy 62 Symptom severity 62 nephrectomy 62 variance ANOVA 62 pulmonary arterial 62 CANCIDAS 62 plasma viremia 62 clinically meaningful improvements 62 eNO 62 dose atorvastatin 62 Score IPSS 62 postdose 62 SSRI SNRI 62 retest reliability 62 achieved statistical significance 62 liver transplant recipients 62 LUTS 62 serum calcium 62 Brief Psychiatric 62 echocardiographic parameters 62 HAQ DI 62 symptom exacerbation 62 rCBF 62 normothermic 62 mesalamine granules 62 DAPT 62 plasma pharmacokinetics 62 OGTT 62 ADAS Cog 62 femoral neck BMD 62 biopsy Gleason 62 androgen ablation 62 COPD exacerbation 62 Logistic regression analysis 62 XIENCE V PROMUS Stent 62 FDG uptake 62 adjuvant tamoxifen 62 anti HBs 62 urinary albumin 62 PCWP 62 CIMZIA TM certolizumab pegol 62 methotrexate therapy 62 BMI z 62 REYATAZ r arm 62 virologic responses 61 ALT elevations 61 NPH insulin 61 Severity Index PASI 61 Meta analyzes 61 multivariable Cox 61 hemodilution 61 autonomic dysfunction 61 leukocyte counts 61 dose proportionality 61 DAS# scores 61 adenoma recurrence 61 neurologic progression 61 nephron sparing surgery 61 symptomatic intracranial hemorrhage 61 leucopenia 61 transaminase levels 61 extubation 61 STN stimulation 61 nonfatal MI 61 pretest probability 61 oral diclofenac 61 fasting insulin 61 plasma renin 61 baseline Hb 61 advanced neoplasia 61 -#.# log# 61 histologically proven 61 atrioventricular block 61 euthymic 61 Pred Forte 61 mIU ml 61 tracer uptake 61 imatinib therapy 61 systolic BP 61 mucosal inflammation 61 BoNTA 61 N telopeptide 61 corticosteroid dose 61 intestinal permeability 61 dose clopidogrel 61 aPTT 61 fibrinolysis 61 #mg BID [001] 61 serum HCV RNA 61 #.#ng/ml 61 NAbs 61 crossclamp 61 lymph node metastasis 61 cytoreductive nephrectomy 61 OPCAB 61 randomized multicenter trial 61 plasma homocysteine 61 nulliparous women 61 bacteriuria 61 symptom severity 61 atherogenic dyslipidemia 61 TEAEs 61 Kaplan Meier estimate 61 amisulpride 61 mcg albinterferon alfa 2b 61 FDG-PET/CT 61 angiographically 61 cranial irradiation 61 glycated hemoglobin HbA1c 61 angiographic outcomes 61 transurethral resection 61 serum parathyroid hormone 61 preoperative chemotherapy 61 echocardiographic 61 MBq 61 serum aminotransferase levels 61 4mg/kg 61 μg L 61 T1DM 61 Viral load 61 lymphovascular invasion 61 abnormal cytology 61 % CI #.#-#.# [004] 61 ml kg 61 interrater 61 C#BL/#J mice 61 preoperative diagnosis 61 intravenous diuretics 61 confidence interval #.#-#.# 61 μg ml 61 interindividual variability 61 CK MB 61 aldosterone antagonist 61 hypogonadal men 61 mCi 61 comparator arm 61 TT genotype 61 Multivariate analyzes 61 pairwise comparisons 61 advanced adenoma 61 ± SD 61 cellularity 61 haematological 61 tryptophan depletion 61 locoregional recurrence 61 Wistar rats 61 beta blocker therapy 61 prospectively defined 61 endoscopic remission 61 meta regression 61 serum albumin 61 odds ratios ORs 61 haematuria 61 mRNA expression 61 hypokalemia 61 serum bilirubin 61 post operatively 61 ERalpha 61 anti Xa 61 p = #.# [004] 61 splenic 61 tipranavir ritonavir 61 paricalcitol 61 nmol liter 61 acetabular fractures 61 Logistic regression 61 HbA1c levels 61 serum testosterone levels 61 comorbid disorders 61 pathologic examination 61 achieved CCyR 61 doxorubicin docetaxel 61 proton MR spectroscopy 61 fructosamine 61 tPSA 61 retrospective cohort 61 albumin excretion 61 endothelium dependent 61 left ventricular diastolic 61 comorbid depression 61 Visual acuity 61 GI motility 61 vitreous haze 61 FOSRENOL ® 61 TIMP 1 61 serum ALT 61 acute cholecystitis 61 neurocognitive deficits 61 inflammatory biomarkers 61 anemia hemoglobin 61 IELT 61 seminal vesicle invasion 61 parathyroidectomy 61 mL kg 61 intravesical therapy 61 UPDRS 61 BRCA2 mutation carriers 61 distal radial fractures 61 statistical significance p 61 neuroleptic 61 inotropic agents 61 SpO 2 61 μg mL 61 hMG 61 voiding dysfunction 61 tumor perfusion 61 coronary revascularization 61 clinicopathologic 61 AUA Symptom Score 61 urate lowering therapy 61 Gram stain 61 FDA defined valvulopathy 61 tHcy 61 cerebral oxygen saturation 61 serum sodium 61 polyp detection 61 Partial Response 61 pretreatment baseline 61 ^ sup #m 61 ± SEM 61 IQR 61 multivariable adjusted 61 Kaplan Meier method 61 lowest tertile 61 cTnT 61 lateral radiograph 61 advanced adenomas 61 serum ferritin 61 serum potassium 61 radial artery grafts 61 pharmacokinetic PK profile 61 peak VO2 61 subscore 61 elevated IOP 61 nonfasting triglyceride levels 61 neurodevelopmental outcomes 61 affective psychoses 61 comorbid conditions 61 covariates 61 cortical activation 61 serum vitamin D 61 saline infusion 61 logistic regression analysis 61 pharmacokinetic characteristics 61 subthreshold depression 61 virologic breakthrough 61 postoperative AF 61 eplerenone 61 posterolateral fusion 61 euthymic patients 61 enthesitis 61 sacral neuromodulation 61 reflux esophagitis 61 ACR Pedi 61 asthma exacerbation 61 adjuvant radiotherapy 61 mIU L 60 pg mL 60 ADCS ADL 60 mg BID dose 60 TMP SMX 60 comorbidity 60 galiximab 60 mucinous 60 hyperoxia 60 serum lactate 60 visceral metastases 60 Stent thrombosis 60 highest tertile 60 intraclass correlation coefficients 60 multivariate regression analysis 60 heterozygotes 60 drug eluting stent implantation 60 enhanced sonography 60 incontinence episodes 60 p = .# [001] 60 urothelial cancer 60 paroxysmal AF 60 sensitivity specificity 60 ng dL 60 oxyhemoglobin 60 TMC# r 60 ALT normalization 60 transurethral 60 thrombocytopenic 60 LV dysfunction 60 bronchoalveolar lavage BAL 60 peri procedural 60 aminotransferase 60 dehydroepiandrosterone sulfate 60 hematopoietic cancers 60 pamidronate 60 HBeAg positive patients 60 nonmetastatic 60 d dimer 60 insulin detemir 60 MACCE 60 UPDRS motor 60 placebo dexamethasone 60 elevated LDH 60 ropivacaine 60 calcaneal fractures 60 paresthesias 60 HBsAg 60 LNG IUS 60 reinfarction 60 concurrent chemoradiation 60 spine BMD 60 elevated troponin 60 trials RCTs 60 prodromal symptoms 60 6MWD 60 vesicoureteral reflux 60 anastomotic leak 60 #mmHg [001] 60 mg QD 60 wound dehiscence 60 DLQI 60 pelvic lymphadenectomy 60 graft occlusion 60 FDG PET imaging 60 undetectable HCV RNA 60 daytime alertness 60 thiopurine 60 APTIVUS r 60 plasma folate 60 femoral shaft fractures 60 Prostate specific antigen 60 liver metastasis 60 mcg QD 60 KRAS mutations occur 60 normotensive 60 ADCS CGIC 60 noncardiac 60 tertile 60 prespecified secondary 60 laboratory abnormalities 60 trastuzumab Herceptin ® 60 pathologic diagnosis 60 hormone receptor status 60 baseline CD4 60 PRADAXA #mg 60 postoperative radiotherapy 60 intratympanic 60 tumor resection 60 hindfoot 60 EBRT 60 urinary calcium 60 intravascular hemolysis 60 gadolinium enhanced 60 mEq L 60 gm dl 60 hypocalcemia 60 pg ml 60 hemoglobin A1c HbA1c 60 renal biopsy 60 preterm neonates 60 HepG2 cells 60 lanthanum carbonate 60 Doppler sonography 60 Hypotension 60 preoperative evaluation 60 % CI #.#-#.# [005] 60 secondary efficacy endpoint 60 postoperative radiographs 60 metastatic lymph nodes 60 ml min 60 dyspareunia 60 IV bisphosphonates 60 corrected QT interval 60 HIV HCV coinfected 60 cytoreduction 60 varicoceles 60 achieved ACR# 60 zoledronate 60 chemosensitivity 60 nodular partial response 60 intraoperative complications 60 IPSS 60 QTc intervals 60 intravitreal injections 60 premorbid 60 postoperative infection 60 antidiabetic medications 60 coronary calcification 60 mean ± SEM 60 χ 60 osmolality 60 tolterodine 60 baseline FEV 60 glycemia 60 HAM D# 60 ELBW infants 60 HER2 overexpression 60 LPV r 60 randomisation 60 p = 60 operable breast cancer 60 adjuvant systemic 60 iodixanol 60 percutaneous drainage 60 TIMP 60 carotid intima media 60 DLTs 60 repigmentation 60 hyperintensity 60 T2DM 60 mcg ml 60 T2 lesions 60 sputum eosinophils 60 thyroidectomy 60 radical cystectomy 60 antihypertensive therapy 60 MetS 60 reoperations 60 nicardipine 60 Radiographic 60 Multiple logistic regression 60 revision hip arthroplasty 60 cortisol secretion 60 isoproterenol 60 Target Lesion Revascularization TLR 60 ß blockers 60 transdermal estradiol 60 oral naltrexone 60 AGHD 60 neurocognitive outcomes 60 vastus lateralis 60 bezafibrate 60 nondepressed 60 Leydig cell 60 activated partial thromboplastin 60 serum glucose 60 rt PA 60 patients evaluable 60 lispro 60 lipid lowering agents 60 urinary excretion 60 lamotrigine 60 colonoscopic 60 neurodevelopmental impairment 60 PEG IFN 60 methacholine 60 spontaneous bowel movements 60 graft patency 60 intravenous cyclophosphamide 60 Retreatment 60 blood glucose concentrations 60 symptomatology 60 colorectal liver metastases 60 octreotide LAR 60 nonvertebral fractures 60 pegylated IFN 60 CC genotype 60 cytological 60 aminotransferase levels 60 HGPIN 60 #mg/day [002] 60 Score DAS# 60 cardiac magnetic resonance 60 conventional angiography 60 HAMD 60 epididymal 60 μg dl 60 pericardial effusion 60 hepatic metastases 60 acetabular dysplasia 60 concomitant antibiotics 60 #F FDG PET 60 prolactin elevation 60 arteriolar 60 radiographic findings 60 thromboembolic 60 recurrent VTE 60 nonresponders 60 hyperalgesia 60 dimensional echocardiography 60 serum retinol 60 transthoracic 60 seronegative